These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17189406)

  • 1. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
    Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
    Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
    Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of methylated free circulating DNA in colorectal cancer.
    Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
    Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation in serum of breast cancer patients: an independent prognostic marker.
    Müller HM; Widschwendter A; Fiegl H; Ivarsson L; Goebel G; Perkmann E; Marth C; Widschwendter M
    Cancer Res; 2003 Nov; 63(22):7641-5. PubMed ID: 14633683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
    Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic DNA methylation marker in serum of cancer patients.
    Müller HM; Fiegl H; Widschwendter A; Widschwendter M
    Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
    Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
    Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer.
    Philipp AB; Nagel D; Stieber P; Lamerz R; Thalhammer I; Herbst A; Kolligs FT
    BMC Cancer; 2014 Apr; 14():245. PubMed ID: 24708595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker.
    Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L
    Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma?
    Cengiz O; Kocer B; Sürmeli S; Santicky MJ; Soran A
    Med Sci Monit; 2006 Jun; 12(6):CR240-7. PubMed ID: 16733481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
    Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
    Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
    Henrique R; Ribeiro FR; Fonseca D; Hoque MO; Carvalho AL; Costa VL; Pinto M; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    Clin Cancer Res; 2007 Oct; 13(20):6122-9. PubMed ID: 17947477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.